Alliance of U.S. Startups and Inventors for Jobs

In a new policy agenda, @USIJorg outlines next steps for lawmakers on how to boost innovation and beat China. Check it out: buff.ly/41ak3QM

It is time to return to first principles and strengthen the patent system for those it was intended to serve. Learn more about how patents can empower startups and inventors: buff.ly/GKi50UM

Drug development remains one of the most difficult and uncertain forms of innovation. Researchers and startups invest years of work and billions of dollars into therapies that may never reach patients. Patents provide a foundation for that risk-taking. They give inventors and investors confidence that, if a breakthrough succeeds, it can be protected, commercialized, and scaled. See our new LinkedIn article: buff.ly/K6qOuK9

"No group of companies should be able to decide -- using effectively closed processes -- who gets to compete and who doesn't." Check out @DrewForNevada's latest op-ed on what Big Tech is doing to suppress innovation and competition in streaming: buff.ly/ip0inLq

Learn why innovators support the RESTORE Patent Rights Act ⬇️

The founding fathers recognized that the new and free society they were enshrining needed an incentive to take risks and an assurance to protect risk-takers. Learn more: buff.ly/43As6l0

On March 26, 2026, USIJ filed an amicus brief in Dolby Laboratories Licensing Corporation v. Unified Patents, LLC, urging the Supreme Court to grant certiorari and reverse a Federal Circuit decision that leaves patent owners without recourse when IPR petitioners conceal the real parties in interest behind their challenges. See it here: buff.ly/ArBiIak

Innovation drives progress, like safer cars and better medicines. 🚗 But with lifesaving therapies, critics allege that drug companies only improve medicines to keep prices high. They've dubbed this practice "product hopping." We're setting the record straight. Learn about this patent myth: c4ip.org/patent-myth-vi…

@InHealthPolicy There's nothing insidious about patents! Patents provide necessary assurance to investors -- allowing developers, who are often small businesses and startups, to create vital and life-saving medications.

Consumer Group Urges HHS To Override Patents As Semaglutide Generics Face U.S. Delay ow.ly/YwE8106wBW0

It might be April fool’s day… but we aren’t joking. If America wants to retain its competitive edge, Congress must pass legislation like PREVAIL and RESTORE to repair our #patent system. #PatentsMatter

“Cases are falling through the cracks -- and in each instance, the beneficiary of PTAB’s inconsistency is a large, often foreign, infringer, while the victim is an American innovator.” Learn more: buff.ly/snCi3rO

Last week, fmr Deputy USTR Jeff Gerrish spoke at "China: The Threats You Know About and the Ones You Don't" for @BreitbartNews. Watch his panel here: buff.ly/QiS7K5d

💡 💡 💡

DYK medical device innovator Masimo has been forced to defend against nearly 30 PTAB challenges in just a few years? Learn how PTAB reforms would end this "efficient infringement" below: buff.ly/dXxLIha

Our members are committed to promoting a strong intellectual property system that supports innovation, investment, and breakthrough technologies that change our world. Learn more about them here: buff.ly/VCrHOzr

⬇️ ⬇️ ⬇️

It is difficult and perilous to start any new company from scratch. The process requires visionary people willing to give up secure jobs, take risks, and join companies that have a significant possibility of failure. Learn how patents support this process: buff.ly/43As6l0

"At a moment when Beijing is pouring resources into biotechnology, Congress should be working to keep America in the lead. That means strengthening the intellectual property protections that spur investment and working with the administration to cut red tape and make it easier for companies to research, develop, and manufacture medicines in America." Read more from fmr Deputy USTR Jeff Gerrish in @TownhallCom: buff.ly/AfPIT59

The United States is still the best at creating new apps, games and social media platforms, but without predictable patent protections in areas like life science, AI, robotics, networking software, and other key sectors, we risk falling behind in core technologies. Learn more: buff.ly/43As6l0

ICYMI: Fmr. Deputy USTR Jeff Gerrish and @Council4IP's Andrei Iancu recently published an op-ed for @FoxNews on how the Trump administration is standing against foreign free-riding and boosting intellectual property protections. Give it a read: buff.ly/kcJV69n

"For American startups, inventors, entrepreneurs, and the venture capital investors who back them, these reforms are essential. The USPTO's NPRM would help ensure that patents provide the certainty needed to invent, invest, grow, and hire -- and compete on a level playing field." buff.ly/XHdekN5